Catabasis pharmaceuticals inc (CATB)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
Assets
Current assets:
Cash and cash equivalents

13,344

9,899

17,765

9,615

11,652

15,294

19,876

49,931

17,030

16,369

21,713

29,369

31,795

23,596

26,464

24,278

23,818

62,780

72,709

81,548

14,668

Short-term investments

41,759

26,345

22,850

36,496

40,012

22,276

23,363

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

14,931

20,803

18,539

28,758

-

-

-

-

Prepaid expenses and other current assets

2,037

2,714

2,111

880

985

1,345

1,302

752

889

1,094

1,099

892

1,020

1,001

1,032

912

810

772

591

528

354

Total current assets

57,140

38,958

42,726

46,991

52,649

38,915

44,541

50,683

17,919

17,463

22,812

30,261

32,815

39,528

48,299

43,729

53,386

63,552

73,300

82,076

15,022

Right-of-use asset

1,799

2,349

965

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

-

-

-

-

48

-

45

51

258

321

388

442

494

568

641

718

770

504

216

230

288

Restricted cash

-

-

-

-

113

-

113

113

113

113

113

113

113

113

-

113

113

113

113

113

113

Right-of-use asset

-

-

-

1,274

1,577

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

237

473

143

264

110

254

-

-

-

-

-

-

-

-

-

-

-

-

28

35

541

Total assets

59,176

41,780

43,834

48,529

54,497

39,169

44,699

50,847

18,290

17,897

23,313

30,816

33,422

40,209

48,940

44,560

54,269

64,169

73,657

82,454

15,964

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

709

1,197

2,156

1,390

1,588

1,408

1,047

785

1,115

773

1,202

2,055

942

1,405

1,721

1,559

1,626

1,328

1,783

2,486

1,132

Accrued expenses

3,002

2,610

2,476

2,512

1,451

2,763

2,730

2,999

2,164

2,432

2,740

2,796

3,294

3,677

3,595

2,656

2,615

3,278

2,437

2,563

2,793

Current portion of operating lease liabilities

879

1,225

929

1,266

1,259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of notes payable, net of discount

-

-

-

-

-

-

-

831

1,657

2,479

3,296

3,278

3,260

3,243

3,225

3,207

3,190

3,173

3,191

2,346

309

Other liability

-

-

-

-

-

-

348

346

341

332

321

-

-

-

-

-

-

-

-

-

-

Total current liabilities

4,590

5,032

5,561

5,168

4,298

4,171

4,125

4,961

5,277

6,016

7,559

8,129

7,496

8,325

8,541

7,422

7,431

7,779

7,411

7,395

4,234

Deferred rent, net of current portion

-

-

-

-

-

-

55

74

82

89

97

-

26

53

-

-

13

26

39

42

67

Notes payable, net of current portion and discount

-

-

-

-

-

-

-

-

-

-

-

831

1,657

2,479

3,296

4,109

4,917

5,720

-

-

4,439

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

108

Notes payable, net of current portion and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,549

7,352

-

Other long-term liabilities

-

-

-

-

-

56

-

-

-

-

-

306

288

266

242

215

184

151

114

77

23

Long-term portion of operating lease liabilities

875

1,028

-

-

330

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

5,465

6,060

5,561

5,168

4,628

4,227

4,180

5,035

5,359

6,105

7,656

9,266

9,467

11,123

12,079

11,746

12,545

13,676

14,113

14,866

8,871

Commitments (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

-

0

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value per share, 5,000,000 shares authorized and no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value per share, 150,000,000 shares authorized; 17,897,172 and 12,433,600 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

18

12

12

12

11

7

71

71

29

2

23

22

20

19

19

15

15

15

15

15

1

Additional paid-in capital

285,257

259,305

255,248

253,821

253,200

232,243

231,697

231,306

191,988

183,224

181,571

180,448

175,881

173,141

172,137

159,664

159,123

158,488

157,933

157,493

2,326

Accumulated other comprehensive loss

-15

-

-

1

-

-4

-5

-

-

-

-

-

-

-4

-3

8

14

-

-

-

-

Accumulated deficit

-231,549

-223,597

-216,987

-210,473

-203,342

-197,304

-191,244

-185,565

-179,086

-171,434

-165,937

-158,920

-151,946

-144,070

-135,292

-126,873

-117,428

-108,010

-98,404

-89,920

-75,380

Total stockholders' equity

53,711

35,720

38,273

43,361

49,869

34,942

40,519

45,812

12,931

11,792

15,657

21,550

23,955

29,086

36,861

32,814

41,724

50,493

59,544

67,588

-73,053

Total liabilities and stockholders' equity

59,176

41,780

43,834

48,529

54,497

39,169

44,699

50,847

18,290

17,897

23,313

30,816

33,422

40,209

48,940

44,560

54,269

64,169

73,657

82,454

15,964